It should be noted that the effects seen on GBM cells with COX1 and COX2 inhibitors in vitro are obtained at concentrations above those required to inhibit the purified recombinant human enzymes, although these concentrations are similar to those used by many other studies of cancer cells in the literature. The gene discussed is PTGS1; the disease is glioblastoma.